$11 billion biotech binge fuels forecasts of 2018 M&A surge

LONDON (Reuters) - An $11 billion burst of biotech bids in just four days has fueled expectations of a 2018 surge in life science deals as large drugmakers shop for promising assets from smaller rivals.